The Grifols family and Brookfield are exploring a takeover bid to take the company private.
Family saga and Canadian firm seek information from board to assess bid for 100% of blood products maker. Group’s share price has fallen 39% this year after Gotham City Research attacks
A takeover bid for Grifols is underway. The blood products maker’s founding family and Brookfield are exploring the possibility of making a bid for 100% control of the company and delisting it.stock market.
Grifols and the Canadian company requested information from the company’s board of directors this Sunday in order to gain access to certain assets, the Catalan group of the National Securities Market Commission (CNMV) said.
A takeover bid for Grifols is underway. The blood products maker’s founding family and Brookfield are exploring the possibility of making a bid for 100% control of the company and delisting it.stock market.
As reported by the Catalan group of the National Securities Market Commission (CNMV), Grifols and the Canadian company requested information from the company’s board of directors on Sunday in order to gain access to certain information to “carry out the process due diligence regarding the possible acquisition of Grifols shares” with the ultimate aim of taking the company private.
The company’s top management and potential bidders have reached an agreement on how to value the transaction, although the company clarifies that it does not know whether the transaction will ultimately be carried out and under what conditions.
THERE WILL BE EXPANSION